RBPJ and neoplasm: This notion is in line with our observations that RBP-J in macrophages is required for inhibition of T cell proliferation under both ex vivo and in vitro M2-polarizing conditions (Fig. 3A and 3B) and suggests that antagonizing RBP-J activities in TAMs may represent a novel strategy of anti-tumor immune-therapy via boosting T cell responses.